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COVID-19 is a respiratory disease that causes severe
pneumonia and sepsis. It affects mainly the lungs, but its
effects on other organs can reflect the severity of sepsis in a
patient. Arterial and venous thrombosis have been noted in
necropsy studies, suggesting a direct and/or indirect action
of the virus on the endothelium and the coagulation cascade.
Endothelial involvement in bacterial and viral infections is
not a new finding. It is known to be mediated by cytokines
and has been shown to occur in pneumonia caused by influ-
enza (1,2). In the case of influenza infection, the prevalence of
myocardial infarction and associated mortality rates is higher
among patients X65 years of age. The impact on mortality is
alleviated by vaccine immunization. Influenza also affects
the incidence of stroke in hypertensive patients. Myocarditis,
mediated by cytokines caused by a direct effect of the virus
on myocytes, has also been described.
Myocardial infarction and myocarditis have been des-
cribed in 20-30% of patients hospitalized for COVID-19.
They are associated with a significant increase in the risk of
all-cause mortality (3). Stroke has also been reported as a result
of large-vessel occlusion in young patients with COVID19 –
one more aspect of the conundrum that is being studied
during this pandemic. COVID-19 is more aggressive than
previous viral respiratory diseases, and systemic manifesta-
tions are expected to be more severe. One study showed the
presence of the virus in the vessel wall, indicating direct infec-
tion (4); this also has been seen in other infectious diseases.
Disseminated intravascular coagulation (DIC) occurs in seve-
ral different infectious diseases, especially those progressing to
sepsis.
Deep venous thrombosis (DVT) is a frequent finding in
intensive care unit (ICU) patients when investigated with
Ultrasound (US) Doppler. The incidence of DVT is between
25% and 32% without prophylaxis and drops to between
10% to 18% when low-molecular-weight heparin is used (5).
Most of these venous obstructions occur in calf veins and are
clinically undetectable. They can cause pulmonary embolism
(PE), often resulting in obstruction of small branches of the
pulmonary arteries; however, many of these PEs are also
clinically undetected, especially in patients with pneumonia
on assisted ventilation.
New pathophysiology of COVID-19 cannot be established
based on the observations of DIC, small artery thrombosis, or
DVT in COVID-19. We may be facing a new viral pneumonia
more aggressive than other previously known ones, with a
more severe involvement of the vascular system.
No viral pneumonia has ever been studied with so much
depth. Because of the worldwide impact of COVID19, the
disease is being critically examined, including detailed auto-
psy examinations and laboratory testing. However, there are
obstacles to assessing the vascular involvement of COVID-
19. Doppler US is not feasible to examine these patients only
for research purposes because of potential exposure of
radiologists and technicians to the virus and potential virus
spread through probes and other components of the US
system that could act as fomites. Lung CT-scans for the
diagnosis of COVID-19 are performed without contrast
media, not permitting the evaluation of pulmonary arteries.
The administration of contrast (for research purposes only)
would be deleterious to the already affected kidney. Thus,
only necropsy reports are available as valuable data, and
these necropsies are likely being conducted in much detail
than has ever been done in other viral infections.
There is an accumulation of data on the involvement of the
vascular system in COVID-19, and new findings are
expected to be revealed shortly. It is a new virus. We just
have to be careful enough to not reinvent the wheel.
If, on one hand, uncertainties and controversies surround
knowledge about the transmission mechanisms, epidemio-
logical curves, immunity, pathophysiology, and treatment of
COVID-19, on the other hand, a drastic change in the routine
practice of vascular surgery, as a medical specialty, has been
quite homogeneous in many countries and continents.
Working in a general hospital, with 900 beds transformed
to serve exclusively patients affected by COVID-19, obser-
ving 200 intensive care unit beds being quickly filled by the
uninterrupted arrival of new patients, and being obliged to
transform surgical rooms into new ICU beds, what seemed
to be a distant Asiatic epidemic has crystallized to a harsh
and suffering reality.
Recognized as an unparalleled challenge by colleagues
from the American and from the European Societies of
Vascular Surgery, some who have lived and others who are
still living in the epicenter of this terrible pandemic, with
some days of delay we felt in Brazil the bitter taste of the
same sanitary convulsion. São Paulo State, in which more
than 20,000 diagnosed cases, has more than 1700 deaths
attributed to the virus so far, compared to New York, Italy,
and Spain. This has transformed the astonishment of thoseDOI: 10.6061/clinics/2020/e1979
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who considered the disease a distant occurrence into a sad
and real experience (6).
Our entire hospital complex has around 2000 beds. With a
coordinated administrative effort, it was possible to allocate
non-COVID-19 patients in separate institutes, moving the
vascular surgery ward. However, this allocation was
followed by an immediate change in the surgical routine
and suspension of all elective cases. As the specialty deals
with emergency cases daily, such as ruptured or sympto-
matic aneurysms with imminent rupture, only these and
other acute cases became part of a restricted number of
operations that included severe cases of critical limb ischemia
with a high risk of amputation or life-threatening infections.
Curiously, due to mechanisms not yet thoroughly under-
stood, even the volume of these emergencies has decreased
when compared with the usual volume. More deaths may be
occurring at home, due to patients’ fear of coming to the
hospitals. This may be another cause of mortality, indirectly
caused by the virus.
By separating infected and non-infected patients into
separate quarters, a logical strategy of facing this pandemic
and curbing this highly transmissible disease would be to
avoid transit between quarters. However, this strategy will
cause an extra problem in team management since this will
lead to the creation of two populations of patients with
vascular emergencies. Emergency staff rotation had to be
organized, with the difficulty of personnel shortage. But,
soon, special abilities of each specialty began to be jointly
completed to fight the disease: the vascular teams assumed
the care of the accesses and catheters for central venous
monitoring or dialysis in the COVID ICUs. Thus, the
complications of these procedures started to increase because
they were frequently performed by less experienced teams.
The infection of team members is highly likely during this
process, and protective equipment became mandatory,
increasing tension and anxiety in the teams. Regular face-
to-face meetings were replaced, when possible, by virtual
meetings, bringing also significant changes to routine and
relationships. Concerns with the teaching and specific
surgical training caused anxiety to residents and fellows.
This moment is one of profound reflection. The humani-
tarian attitude displayed by residents as volunteers who
have traveled to infected areas, comforting patients and
families, can compensate the negative aspects this disease
can cause and can open the possibility for personal growth in
these trainees
The pandemic is still growing, but our knowledge of it also
continues to improve. The outlook is optimistic considering
that some patients have already been cured of it and a vast
amount of knowledge has been gathered so far. Also, young
doctors are incorporating this priceless experience into their
personal and professional growth.
This phrase can convey a little hope during these difficult
times:
‘‘Today, man, in order to be saved, needs only one thing:
to open his heart to joy’’ – Bertrand Russell
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